Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“Rampant medical malpractices without any effective checks and balances are causing repeated outbreaks in Pakistan.”
15,000 people—including the stars of “Pose”—participated in the event that supports GMHC and other local HIV groups.
Launched by the Banyan Tree Project, #NAPIHAAD is Sunday, May 19.
Four things you should know to be #HepAware.
Federal researchers describe two paths to a vaccine—and one of them uses high-tech computers to design a vaccine candidate!
Gilead Sciences CEO defends high drug prices and claims the CDC does not own the patent to HIV prevention pill Truvada.
Pharma giants made agreements to keep prices high and block competition for generics, the civil lawsuit alleges.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
Global research teams from three U.S. universities explore this HIV-tuberculosis link, thanks to a $6.2 million grant.
This will provide free PrEP to as many as 200,000 uninsured Americans until 2030.
Michel Sidibé “leaves a soiled legacy.”
Only one company will sell a version of the HIV prevention pill Truvada. When others go to market, prices will likely drop further.
New HIV cases in the city remain higher than those in Los Angeles County and the state.
The Queen of Pop recalls the early days of the epidemic and discusses her fight against HIV in Africa.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.